This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Exploration of multiple signaling pathways through which sodium tanshinone IIA sulfonate attenuates pathologic remodeling experimental infarction
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTraditional Chinese Medicine Analysis · Cardiac Fibrosis and Remodeling
The journal retracts the 12 July 2019 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication was identified between Figure 6B and 7B. Some panels of Figure 3C, 6B and 9B were also found to be published in other articles.
The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable, and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. Author MV agrees to this retraction. Authors SM, MC, MZ and AH did not respond to correspondence regarding this retraction.
Frontiers would like to thank the users on PubPeer for bringing the published article to our attention.